Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Plus Therapeutics Inc (PSTV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Plus Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.630 -0.010    -0.61%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
1.660
+0.030
+1.840%
18:00:46 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 17,117
  • Bid/Ask: 1.530 / 1.660
  • Day's Range: 1.610 - 1.683
Plus Therapeutics 1.630 -0.010 -0.61%

PSTV Recent Sentiments

 
This page contains information on users’ sentiments for the Plus Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 15, 2024 ergin dinc   1.930 -15.54%
Mar 07, 2024 INTERNATIONAL FILMS   1.670 Mar 29, 2024 @ 1.805 +8.08%
Jan 24, 2024 Suharjono SUHARJONO   2.160 Feb 16, 2024 @ 2.000 -7.41%
Jan 22, 2024 Serdar Memmedov   2.263 Feb 16, 2024 @ 2.000 +11.62%
Jan 19, 2024 Claudio Tonoli   2.180 Feb 09, 2024 @ 1.970 -9.63%
Dec 29, 2023 Хамза омарович   1.800 Jan 19, 2024 @ 2.150 +19.44%
Dec 19, 2023 A D   1.870 Jan 12, 2024 @ 2.070 +10.70%
Dec 07, 2023 Bongiwe Ndzekeni   2.110 Dec 29, 2023 @ 1.750 -17.06%
Dec 06, 2023 Xpto Xpto   1.870 Dec 29, 2023 @ 1.750 -6.41%
Dec 04, 2023 fabio mazzeo   1.880 Dec 29, 2023 @ 1.750 -6.91%
Nov 28, 2023 Suhar Yanto   1.819 Dec 22, 2023 @ 1.910 +5.00%
Nov 20, 2023 kermit dekikker   1.900 Dec 15, 2023 @ 1.910 -0.53%
Nov 17, 2023 A D   2.240 Dec 08, 2023 @ 2.120 -5.36%
Nov 14, 2023 Chiaretto Calo   1.500 Nov 30, 2023 @ 1.700 +13.33%
Nov 03, 2023 Robbert Kuipers   1.630 Nov 30, 2023 @ 1.700 +4.29%
Nov 03, 2023 Robbert Kuipers   1.630 Nov 03, 2023 @ 1.630 0.00%
Sep 11, 2023 Robbert Kuipers   1.650 Sep 11, 2023 @ 1.650 0.00%
Sep 11, 2023 רונן בן   1.720 Nov 30, 2023 @ 1.700 -1.16%
Aug 11, 2023 Andres Alfaro   2.550 Nov 30, 2023 @ 1.700 -33.33%
Jul 14, 2023 Katherine Simon   2.085 Nov 30, 2023 @ 1.700 -18.47%
Jun 26, 2023 Elisabeth Nieto   2.715 Nov 30, 2023 @ 1.700 +37.38%
Jun 21, 2023 Automation Web   3.130 Jun 21, 2023 @ 3.100 +0.96%
Jun 12, 2023 Ronald Quinto...   3.290 Nov 30, 2023 @ 1.700 -48.33%
May 17, 2023 fabio mazzeo   4.020 Nov 30, 2023 @ 1.700 -57.71%
May 02, 2023 Claudio Tonoli   3.620 Nov 30, 2023 @ 1.700 -53.04%
May 01, 2023 Thomas Wawro   4.080 May 13, 2023 @ 4.320 -5.88%
Apr 28, 2023 Samuel Battaglia   3.750 May 09, 2023 @ 4.210 +12.27%
Apr 21, 2023 Roberto Alessi   4.050 Nov 30, 2023 @ 1.700 -58.02%
Mar 21, 2023 Fabrizio Bicio   0.272 Mar 27, 2023 @ 0.275 -1.10%
Mar 02, 2023 Владимир Демешко   0.332 Mar 24, 2023 @ 0.268 -19.43%
Feb 22, 2023 Claudio Tonoli   0.398 Mar 17, 2023 @ 0.290 -27.14%
Jan 25, 2023 Claudio Tonoli   0.440 Feb 17, 2023 @ 0.361 -17.84%
Dec 20, 2022 Claudio Tonoli   0.340 Jan 13, 2023 @ 0.478 +40.65%
Dec 19, 2022 İsa Köroğlu   0.322 Dec 19, 2022 @ 0.322 0.00%
Nov 29, 2022 Roberto Alessi   0.400 Dec 23, 2022 @ 0.310 -22.50%
Nov 21, 2022 Claudio Tonoli   0.465 Dec 16, 2022 @ 0.301 -35.23%
Nov 15, 2022 İsa Köroğlu   0.460 Dec 09, 2022 @ 0.389 +15.48%
Oct 10, 2022 Varujan Bulgan   0.562 Oct 28, 2022 @ 0.490 +12.81%
Oct 10, 2022 Robbert Kuipers   0.562 Nov 04, 2022 @ 0.424 -24.56%
Oct 10, 2022 Robbert Kuipers   0.562 Oct 10, 2022 @ 0.562 0.00%
Oct 07, 2022 Efatim Nieto   0.623 Oct 28, 2022 @ 0.490 -21.35%
Oct 06, 2022 Алина Соколова   0.530 Oct 28, 2022 @ 0.490 -7.55%
Sep 12, 2022 Yake Yake   0.615 Oct 07, 2022 @ 0.510 -17.07%
Aug 30, 2022 Alexander Schneider   0.874 Sep 23, 2022 @ 0.495 -43.36%
Aug 30, 2022 Claudio Tonoli   0.868 Sep 23, 2022 @ 0.495 -42.97%
Aug 26, 2022 Майра Утегенова   0.860 Sep 16, 2022 @ 0.600 -30.23%
Aug 24, 2022 Robbert Kuipers   0.790 Sep 16, 2022 @ 0.600 -24.05%
Aug 24, 2022 Robbert Kuipers   0.790 Aug 24, 2022 @ 0.790 0.00%
Aug 24, 2022 Robbert Kuipers   0.790 Aug 24, 2022 @ 0.790 0.00%
Aug 24, 2022 Robbert Kuipers   0.810 Aug 24, 2022 @ 0.790 -2.47%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PSTV Comments

Write your thoughts about Plus Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Chiaretto Calo
Chiaretto Calo Nov 14, 2023 6:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
According to analysts, PSTV stock is rated as a "Strong Buy." The average 12-month stock price forecast is $10.00, representing a substantial increase of over 525% from the current price​​​​​​. Innovative Drug Development: Plus Therapeutics focuses on developing treatments for cancer and other diseases. Their lead drug candidate, Rhenium-186Re obisbemeda, targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. They are also working on other promising treatments for solid organ cancers​​. FDA Orphan Drug Designation: The company recently received U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the treatment of breast cancer with leptomeningeal metastases. This designation can provide certain benefits, including market exclusivity upon approval, assistance in clinical study design, tax credits, and exemption from FDA user fees​​. Share Repurchase Program: Plus Therapeutics announced a share repurchase program, indicating confidence in their financial stability and future prospects​​. Clinical Trial Progress: The company has been making progress in its clinical trials. For instance, they completed dosing in Cohort 4 of the ReSPECT-LM Phase 1 Clinical Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases and plan to move into the next cohort following safety reviews​​​​.
Nash Purswani
Nash Purswani Dec 07, 2022 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can we file a case against all these analysts who hv giving fake hopes
Péter Dovák
Péter Dovák Aug 18, 2022 6:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wondering if it hits 2+
Nash Purswani
Nash Purswani Aug 05, 2021 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zero sales but everyone says strong buy - always confused with this Co but stuck n feels like slow quiksand
Dragan Soldat
Dragan Soldat Aug 05, 2021 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Like others they are expecting discovery of a candidate and then boom It happens but rare
Nash Purswani
Nash Purswani Aug 05, 2021 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My thoughts also
Pochette Million
Pochette Million Apr 15, 2020 11:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its a very strong buy
En Game
En Game Apr 15, 2020 11:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I guess its an even stronger buy today
victor cruz
victor cruz Nov 14, 2019 4:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its merging from the ashes now.
Scott Wallace
Scott Wallace Sep 23, 2019 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Really what happened????
Sarika Ramonda
Sarika Ramonda Sep 23, 2019 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$PSTV Plus Therapeutics, Inc. Announces Pricing Of $15 Million Underwritten Public OfferingThe Series U Warrants have an exercise price of $5.00 per share
Jack Wood
Jack Wood Sep 23, 2019 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stupid firm offered millions of share mid-day at 5$ while stock was still trading at 10$. It just took few seconds to drop to 4$. It was unfair of them to do offering at 5$ as lots of bulls got trapped within seconds.
Roland Jambrich
Roland Jambrich Sep 23, 2019 3:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
After 8 yesterday, first 16, then 3,56 today? What's going on here?
ANDREA YACHTSMAN
ANDREA YACHTSMAN Aug 22, 2019 12:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1:50
Nash Purswani
Nash Purswani Aug 16, 2019 11:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone holding the cytori warrants and know how it will be converted - same 50:1 ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email